Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China – A Mixed Method Research Study

References

• WHO. Global Tuberculosis Report, 2020. Geneva: World Health Organization; 7, 2020. Available from: https://www.who.int/. Accessed 225, 2021.
   Google Scholar
• WHO. The End TB Strategy. Geneva: World Health Organization; 2014. Available from: https://www.who.int/. Accessed 7, 2020.
   Google Scholar
• Cheng SM. Current situation and recommendation of MDR-TB prevention and control in China. China Trop Med. 2017;17(3):213–215.
   Google Scholar
• Loveday M, Wallengren K, Brust J, et al. Community-based care vs. centralized hospitalization for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2015;19(2):163–171. doi:10.5588/ijtld.14.036925574914
   PubMed Web of Science ®Google Scholar
• Wai PP, Shewade HD, Kyaw NTT, et al. Community based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar. PLoS One. 2018;13(3):e0194087. doi:10.1371/journal.pone.019408729596434
   PubMed Web of Science ®Google Scholar
• Oyieng’o D, Park P, Gardner A, et al. Community-based treatment of multidrug-resistant tuberculosis: early experience and results from Western Kenya. Public Health Action. 2012;2(2):38–42. doi:10.5588/pha.12.000226392946
   PubMedGoogle Scholar
• Zou GY, Wei XL, Walley JD, et al. Factors influencing integration of TB services in general hospitals in two regions of China: a qualitative study. BMC Health Serv Res. 2012;12(1):21. doi:10.1186/1472-6963-12-2122276746
   PubMed Web of Science ®Google Scholar
• Li Y, Ehiri J, Oren E, et al. Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China. PLoS One. 2014;9(2):E88330. doi:10.1371/journal.pone.008833024505476
   PubMed Web of Science ®Google Scholar
• Tadesse T, Demissie M, Berhane Y, et al. Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study. BMC Public Health. 2013;13(1):424. doi:10.1186/1471-2458-13-42423634650
   PubMed Web of Science ®Google Scholar
• Wynne A, Richter S, Banura L, Kipp W. Challenges in tuberculosis care in Western Uganda: health care worker and patient perspectives. Int J Afr Nurs Sci. 2014;1(C):6–10. doi:10.1016/j.ijans.2014.05.001
   Google Scholar
• Bastos ML, Cosme LB, Fregona G, et al. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis. BMC Infect Dis. 2017;17(1):718. doi:10.1186/s12879-017-2810-129137626
   PubMed Web of Science ®Google Scholar
• Liu YH, Wu JG, Zhou GZ, et al. Influencing factors for treatment adherence of patients with multidrug resistant tuberculosis. Chin J Infect Control. 2015;9:593–596.
   Google Scholar
• Ren SJ. Investigation and study of influence of treatment adherence after discharge with MDR-TB patient. China Health Stand Manage. 2016;12.
   Google Scholar
• Qian ML. Study on the influencing factors and countermeasures of treatment compliance in patients with multidrug-resistant tuberculosis. Chin Foreign Med Treat. 2015;22.
   Google Scholar
• Ministry of Health of PRC. National tuberculosis control programme (2011–2015). Available from: http://www.gov.cn/gongbao/content/2011/content_2020914.htm. Accessed 7, 2020.
   Google Scholar
• General office of the state council: national tuberculosis control plan (2011–2015). 2011. Available from: http://www.gov.cn/zwgk/2011-12/06/content_2012869.htm. Accessed 7 2020.
   Google Scholar
• Wei XL, Zou GY, Yin J, Walley J, Sun Q. Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China. BMC Infect Dis. 2013;13(1):93. doi:10.1186/1471-2334-13-9323425261
   PubMed Web of Science ®Google Scholar
• Sun Q, Yin J, Yin X, et al. Does the integration of TB medical services in the general hospital improve the quality of TB care? Evidence from a case study in China. J Public Health. 2013;35(2):322–328. doi:10.1093/pubmed/fds089
   Web of Science ®Google Scholar
• Xu WX, Hu J, Luo YJ. Preliminary evaluation of the treatment effect of drug-resistant tuberculosis patients in Jiaxing City. China Rural Health Serv Administration. 2014;34(03):288–289.
   Google Scholar
• Heller T, Lessells RJ, Wallrauch CG, et al. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010;14(4):420–426.20202299
   PubMed Web of Science ®Google Scholar
• Jelly I, Peters M. Community-based management of multiple drug resistant tuberculosis in a tertiary hospital in Tanzania: a best practice implementation project. JBI Database System Rev Implement Rep. 2017;15(12):3092–3101. doi:10.11124/JBISRIR-2017-003390
   Google Scholar
• Liu Y, Liu J, Jing KH, et al. Analysis on monitoring results of resistance of anti-tuberculosis drug in Chongqing. Mod Prev Med. 2012;39:692–694.
   Google Scholar
• Wang XY, Luo M, Zhang HZ, Wang J. Correlation analysis between rifampicin resistance and multidrug resistance in tuberculosis patients in Chongqing. China Trop Med. 2019;12.
   Google Scholar
• Farrugia B. WASP (write a scientific paper): sampling in qualitative research. Early Hum Dev. 2019;133:69–71. doi:10.1016/j.earlhumdev.2019.03.01630948245
   PubMed Web of Science ®Google Scholar
• Smith J, Firth J. Qualitative data analysis: the framework approach. Nurs Res. 2011;18(2):52–62. doi:10.7748/nr2011.01.18.2.52.c8284
   PubMedGoogle Scholar
• Srivastava A, Thomson SB. Framework analysis: a qualitative methodology for applied policy research. J Administration Governance. 2009;4(2):72–79.
   Google Scholar
• Ward DJ, Furber C, Tierney S, Swallow V. Using framework analysis in nursing research: a worked example. J Adv Nurs. 2013;69(11):2423–2431. doi:10.1111/jan.1212723517523
   PubMed Web of Science ®Google Scholar
• World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, Switzerland: World Health Organization; 1997. Available from: https://www.researchgate.net/publication/274519736_Book_Reviews_Treatment_of_Tuberculosis_guidelines_for_national_programmes_4th_Edition_By_The_World_Health_Organization_Published_by_WHO_Press_2010_Paperback_157pp_Price_2500_ISBN_978_92_4_154783_3?ev=auth_pub. Accessed 7, 2020.
   Google Scholar
• Wang LX, Cheng SM, Chen MT, et al. Report on the fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberculosis. 2012;8. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2012&filename=ZFLZ201208002&v=Yqw4aQ4yBXf6bzPu0fA%25mmd2F0kyPEz63ARf39GLB7k6eXeGIsvqzElxJBAj5nFQecknW. Accessed February 25, 2021.
   Google Scholar
• Zheng L, Xu HL, Yang KY. Study on the Treatment Adherence and Its Influencing Factors of Multidrug-Resistant Tuberculosis (TB) Patients in the Tuberculosis Hospital of Hunan Province. Zhongnan University; 2014. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CMFD&dbname=CMFD201401&filename=1014144715.nh&v=lZYKyFmSRjrgP6%25mmd2FR61i%25mmd2BExJ9ciaWdECv4xB%25mmd2FDwZW%25mmd2BjjBp8RTHqIoJLxu4PzPbPLn. Accessed 7, 2020.
   Google Scholar
• Hao BL, Liu ZF, Ma LP. Univariate analysis of the factors affecting treatment adherence of 98 multidrug-resistant tuberculosis patients. Henan J Prev Med. 2014;4.
   Google Scholar
• Pablos-Méndez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102:164–170. doi:10.1016/S0002-9343(96)00402-09217566
   PubMed Web of Science ®Google Scholar
• Sharma SK, Turaga KK, Balamurugan A, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol. 2003;3:183–188. doi:10.1016/S1567-1348(03)00086-814522182
   PubMed Web of Science ®Google Scholar
• Gelmanova IY, Keshavjee S, Golubchikova VT, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Heal Organ. 2007;85:703–711. doi:10.2471/BLT.06.038331
   PubMed Web of Science ®Google Scholar
• Zhang W, Hu DY, Liu Y, et al. Prevalence of multidrug-resistance in 638 tuberculosis patients in Chongqing. China Trop Med. 2017;3:231–235.
   Google Scholar
• WHO. WHO Companion Handbook to the Who Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014. Available from: https://pubmed.ncbi.nlm.nih.gov/25320836/. Accessed 7, 2020.
   Google Scholar
• Zhou L, Chai CL, Chen SH, et al. Analysis of the outcome of community-managed multidrug-resistant tuberculosis patients. Prev Med. 2017;1.
   Google Scholar
• Lewis JJ, Liu X, Zhang Z, et al. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial. Trials. 2018;19(1):1–12. doi:10.1186/s13063-018-2650-329298706
   PubMed Web of Science ®Google Scholar
• Chaiyachati K, Loveday M, Lorenz S, et al. A pilot study of an mhealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program. PLoS One. 2013;8(5):E64662. doi:10.1371/journal.pone.006466223724075
   PubMed Web of Science ®Google Scholar
• Do D, Garfein R, Cuevas-Mota J, Collins K, Liu L. Change in patient comfort using mobile phones following the use of an app to monitor tuberculosis treatment adherence: longitudinal Study. JMIR Mhealth Uhealth. 2019;7(2):E11638. doi:10.2196/1163830707103
   PubMed Web of Science ®Google Scholar
• Liu X, Lewis JJ, Zhang H, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9):E1001876. doi:10.1371/journal.pmed.100187626372470
   PubMed Web of Science ®Google Scholar
• Wei X, Hicks JP, Pasang P, et al. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet. Trials. 2019;20(1):273. doi:10.1186/s13063-019-3364-x31097023
   PubMed Web of Science ®Google Scholar